drospirenone + ethinyl estradiol + myo-inositol

This entry describes a proposed or hypothetical combination of the established oral contraceptive ingredients drospirenone and ethinyl estradiol with myo-inositol. The combination of drospirenone (a progestin) and ethinyl estradiol (an estrogen) is a well-known hormonal contraceptive found in products like Yasmin. Their combined mechanism of action involves: * Suppressing ovulation * Changing cervical mucus to hinder sperm movement * Creating an unfavorable environment for fertilized eggs in the uterus This two-drug combination is also approved for treating premenstrual dysphoric disorder (PMDD) and moderate acne vulgaris. However, the specific combination that includes myo-inositol alongside drospirenone and ethinyl estradiol is *not directly mentioned* or detailed in the provided search results. While myo-inositol is a naturally occurring substance studied for various potential health benefits, its role, specific properties, approved indications, or development status *in this particular three-drug formulation* are not available based on the given information. The typical dosage mentioned for the *two-drug* drospirenone/ethinyl estradiol combination is 3 mg of drospirenone and 0.03 mg of ethinyl estradiol per tablet. Dosage information for the triple combination is not provided.